I'm not crying 😭

Keep us in god's country

In the API-CAT trial involving patients with active cancer and venous thromboembolism, extended anticoagulation with reduced-dose apixaban was noninferior to full-dose apixaban for preventing recurrent thromboembolic events. Full trial results and Research Summary:

There is no congressional district in America that has a greater stake in Medicaid than my congressional district in the Bronx. The Republican assault on Medicaid is an assault on the Bronx. We cannot let it stand.

Presented at #ATS2025: In the PREDMETH trial, first-line treatment of pulmonary sarcoidosis with methotrexate was noninferior to that with prednisone regarding the change at 24 weeks in the percentage of the predicted forced vital capacity. Full trial results:

NM Pulmonary and Thoracic Surgery Northwestern Feinberg School of Medicine Northwestern Medicine has not received any NIH funds since March. No written communication about why or what can be done. Thank you Ben Singer for raising awareness at #ATS2025

Montefiore-Einstein Pulmonary Medicine at #ATS2025

A new COPD diagnostic schema that includes chest imaging, respiratory symptoms, and spirometry identified more high-risk individuals and excluded low-risk ones. #ATS2025 ja.ma/4dp9i30

Groundbreaking!!

Presented at #ATS2025: In the BATURA trial, as-needed albuterol–budesonide resulted in a lower risk of severe asthma exacerbation than as-needed albuterol among participants with disease that was uncontrolled despite treatment for mild asthma. Full trial results:

Presented at #ATS2025: In the FIBRONEER-ILD phase 3 trial involving patients with progressive pulmonary fibrosis, treatment with nerandomilast led to a smaller decline in the forced vital capacity than placebo over a period of 52 weeks. Full trial results:

Original Article: First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate (PREDMETH trial) nej.md/4kdaf0o Editorial: Methotrexate as Initial Therapy for Symptomatic Pulmonary Sarcoidosis? nej.md/4mhaHfW #ATS2025 | American Thoracic Society (ATS)

As a doctor, I’ve seen pain — but nothing prepares you for a B-787 crashing into an MBBS mess. Students with dreams, passengers with families… all gone in seconds. Not just lives lost, but futures, hopes, and stories left incomplete. #B787 #PlaneCrash

Montefiore-Einstein Pulmonary Medicine & CCM class of 2025! We did it! 🎓

When I was in training my mentors would write a 3-4 sentence chart note that was eloquent and said everything that needed to be said and now notes are 23 pages of slop, and we think that the solution to this is to turn it all over to an artificial form of intelligence.

This will be absolutely devastating in the medical field. ~30% residents are international medical graduates & ~10k of 43k residency spots are filled by docs with H1-B visas. Previously the h-1B fee was <$5,000. No hospital will pay a $100k fee for a $55k resident salary.

Look at the orange line Going down That's cervical cancer cases in the age group that has had the HPV vaccine in England This vaccine prevents cancer!!

(Non-Jewish) opera singer Sarah Callinan was hired to sing at a Rosh Hashana service. She witnessed firsthand the level of security now required for Jews to practice their faith safely. Thank you so much, Sarah, for speaking up. You’re right, this situation is not okay, but your

Check out our article on phenobarbital for alcohol withdrawal! Montefiore Critical Care Medicine Montefiore-Einstein Pulmonary Medicine Nika Blinder Ari Moskowitz link.springer.com/10.1186/s13054…

In med school, I learned that Huntington's disease was one of the most devastating inherited conditions. It caused progressive neurological decline, starting around age 30. There was no treatment. Now, Huntington's has been treated for first time. This is why we fund science.